- Home
- PED vs ETON Comparison
PED vs ETON Comparison
Compare PED & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PED | ETON |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 498.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PED | ETON |
|---|---|---|
| Price | $0.56 | $16.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $1.50 | ★ $29.67 |
| AVG Volume (30 Days) | 148.8K | ★ 207.6K |
| Earning Date | 11-17-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.43 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | $33,244,999.00 | ★ $70,316,000.00 |
| Revenue This Year | N/A | $107.23 |
| Revenue Next Year | $305.89 | $29.72 |
| P/E Ratio | $5.33 | ★ N/A |
| Revenue Growth | N/A | ★ 102.77 |
| 52 Week Low | $0.43 | $11.09 |
| 52 Week High | $1.00 | $23.00 |
Technical Indicators
Market Signals| Indicator | PED | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 46.33 | 47.89 |
| Support Level | $0.54 | $15.83 |
| Resistance Level | $0.60 | $17.17 |
| Average True Range (ATR) | 0.03 | 0.63 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 34.72 | 44.81 |
Price Performance
Historical ComparisonAbout PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.